Moderna prepares to submit RSV vaccine for FDA approval

Researchers are on the cusp of rolling out a new vaccine to combat respiratory syncytial virus amid an increase of cases in recent months.

Related Keywords

Maryland ,United States ,University Of Maryland School Medicine ,James Campbell ,Kim Dacey ,Pfizer ,Glaxosmithkline ,Drug Administration ,Maryland Department Of Health ,Maryland School ,Maryland Department ,Cdc ,Enters For Disease Control And Prevention ,R James Campbell ,Rsv Maryland ,Rsv Cases ,Sv Cases In Maryland ,Rsv Shot ,Rsv Vaccine ,Respiratory Syncytial Virus ,Coronavirus ,Covid ,Covid 19 ,Fda ,Flu ,Influenza ,Moderna ,Oderna Rsv ,Oderna Rsv Shot ,Moderna Rsv Vaccine ,Shot ,Vaccine ,Accine Study ,What Is Rsv ,Plnd ,